187 related articles for article (PubMed ID: 37906565)
61. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
62. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies.
Inadomi JM; Vijan S; Janz NK; Fagerlin A; Thomas JP; Lin YV; Muñoz R; Lau C; Somsouk M; El-Nachef N; Hayward RA
Arch Intern Med; 2012 Apr; 172(7):575-82. PubMed ID: 22493463
[TBL] [Abstract][Full Text] [Related]
63. Cost Effectiveness of Colorectal Cancer Screening Strategies.
Patel SS; Kilgore ML
Cancer Control; 2015 Apr; 22(2):248-58. PubMed ID: 26068773
[TBL] [Abstract][Full Text] [Related]
64. Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral Risk Factor Surveillance System.
Seeff LC; Shapiro JA; Nadel MR
J Fam Pract; 2002 Sep; 51(9):761-6. PubMed ID: 12366896
[TBL] [Abstract][Full Text] [Related]
65. Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination.
Solomon MJ; McLeod RS
CMAJ; 1994 Jun; 150(12):1961-70. PubMed ID: 7980760
[TBL] [Abstract][Full Text] [Related]
66. Comparison of Program Resources Required for Colonoscopy and Fecal Screening: Findings From 5 Years of the Colorectal Cancer Control Program.
Subramanian S; Tangka FKL; Hoover S; Cole-Beebe M; Joseph D; DeGroff A
Prev Chronic Dis; 2019 Apr; 16():E50. PubMed ID: 31022371
[TBL] [Abstract][Full Text] [Related]
67. Colon cancer screening and surveillance controversies.
Lieberman D
Curr Opin Gastroenterol; 2009 Sep; 25(5):422-7. PubMed ID: 19465849
[TBL] [Abstract][Full Text] [Related]
68. Estimates of costs and effects of screening for colorectal cancer in the United States.
Byers T; Gorsky R
Cancer; 1992 Sep; 70(5 Suppl):1288-95. PubMed ID: 1387342
[TBL] [Abstract][Full Text] [Related]
69. Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.
Rex DK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Levin TR; Lieberman D; Robertson DJ
Gastroenterology; 2017 Jul; 153(1):307-323. PubMed ID: 28600072
[TBL] [Abstract][Full Text] [Related]
70. Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests.
Cheng TI; Wong JM; Hong CF; Cheng SH; Cheng TJ; Shieh MJ; Lin YM; Tso CY; Huang AT
J Formos Med Assoc; 2002 Oct; 101(10):685-90. PubMed ID: 12517041
[TBL] [Abstract][Full Text] [Related]
71. Colonoscopy and Sigmoidoscopy Use among the Average-Risk Population for Colorectal Cancer: A Systematic Review and Trend Analysis.
Cardoso R; Niedermaier T; Chen C; Hoffmeister M; Brenner H
Cancer Prev Res (Phila); 2019 Sep; 12(9):617-630. PubMed ID: 31289028
[TBL] [Abstract][Full Text] [Related]
72. Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia.
Lew JB; St John DJB; Macrae FA; Emery JD; Ee HC; Jenkins MA; He E; Grogan P; Caruana M; Sarfati D; Greuter MJE; Coupé VMH; Canfell K
Int J Cancer; 2018 Jul; 143(2):269-282. PubMed ID: 29441568
[TBL] [Abstract][Full Text] [Related]
73. Outpatient colonoscopy complications in the CDC's Colorectal Cancer Screening Demonstration Program: a prospective analysis.
Castro G; Azrak MF; Seeff LC; Royalty J
Cancer; 2013 Aug; 119 Suppl 15():2849-54. PubMed ID: 23868479
[TBL] [Abstract][Full Text] [Related]
74. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
[TBL] [Abstract][Full Text] [Related]
75. Re: Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study.
Schoen RE; Levin TR
J Natl Cancer Inst; 2003 Jun; 95(11):830-1; author reply 831. PubMed ID: 12783941
[No Abstract] [Full Text] [Related]
76. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies.
Brenner H; Stock C; Hoffmeister M
BMJ; 2014 Apr; 348():g2467. PubMed ID: 24922745
[TBL] [Abstract][Full Text] [Related]
77. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force.
Whitlock EP; Lin JS; Liles E; Beil TL; Fu R
Ann Intern Med; 2008 Nov; 149(9):638-58. PubMed ID: 18838718
[TBL] [Abstract][Full Text] [Related]
78. Participation in colorectal cancer screening trials after first-time invitation: a systematic review.
Khalid-de Bakker C; Jonkers D; Smits K; Mesters I; Masclee A; Stockbrügger R
Endoscopy; 2011 Dec; 43(12):1059-86. PubMed ID: 22135196
[TBL] [Abstract][Full Text] [Related]
79. Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"--SCORE.
Segnan N; Senore C; Andreoni B; Aste H; Bonelli L; Crosta C; Ferraris R; Gasperoni S; Penna A; Risio M; Rossini FP; Sciallero S; Zappa M; Atkin WS;
J Natl Cancer Inst; 2002 Dec; 94(23):1763-72. PubMed ID: 12464648
[TBL] [Abstract][Full Text] [Related]
80. Diagnostic Performance of One-off Flexible Sigmoidoscopy with Fecal Immunochemical Testing in a Large Screening Population.
Niedermaier T; Weigl K; Hoffmeister M; Brenner H
Epidemiology; 2018 May; 29(3):397-406. PubMed ID: 29287053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
